A new report by the Washington, DC, Department of Health shows that manufacturers of antipsychotics are pushing high levels of marketing dollars toward Medicaid psychiatrists. Medscape Medical News (Source: Medscape Today Headlines)
via Original Article
via Original Article
No comments:
Post a Comment